Mount Sinai Hosp Med School — New York, New York

Mount Sinai Hosp Med School is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Hosp Med School has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Hosp Med School?

Mount Sinai Hosp Med School has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Hosp Med School conducted?

Mount Sinai Hosp Med School has 2 clinical trials on record, with 2 currently active. Their work covers Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Is Mount Sinai Hosp Med School accredited by Crixeo Health?

Mount Sinai Hosp Med School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Hosp Med School?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.